Medlive Technology Co., Ltd. (HKG:2192)

Hong Kong · Delayed Price · Currency is HKD

7.46

+0.08 (1.08%)

Jul 10, 2026, 4:08 PM HKT

-46.48% (1Y)

Market Cap	5.52B -54.5%
Revenue (ttm)	714.60M +15.0%
Net Income	372.06M +6.1%
EPS	0.50 +6.0%
Shares Out	740.11M
PE Ratio	14.77
Forward PE	14.05
Dividend	0.30 (4.06%)
Ex-Dividend Date	May 19, 2026

Volume	2,259,500
Open	7.41
Previous Close	7.38
Day's Range	7.30 - 7.58
52-Week Range	6.31 - 16.84
Beta	0.43
Analysts	Strong Buy
Price Target	12.77 (+71.18%)
Earnings Date	Aug 25, 2026

About Medlive Technology

Medlive Technology Co., Ltd. operates an online professional physician platform in Mainland China and internationally. The company’s precision marketing and corporate solution provides digital marketing, digital detailing, digital marketing consultation, digital content creation, application software development, and other relevant services. Its medical knowledge solution offers medical education and clinical decision support, including licensing software to physicians and other registered users, such as other healthcare professionals and pharm... [Read more]

Industry Health Information Services

Sector Healthcare

Founded 1996

Employees 724

Stock Exchange Hong Kong Stock Exchange

Ticker Symbol 2192

Full Company Profile

Financial Performance

In 2025, Medlive Technology's revenue was 642.16 million, an increase of 14.99% compared to the previous year's 558.46 million. Earnings were 334.34 million, an increase of 6.09%.

Financial numbers in CNY Financial Statements

Analyst Summary

According to 5 analysts, the average rating for 2192 stock is "Strong Buy." The 12-month stock price target is $12.77, which is an increase of 71.18% from the latest price.

Price Target

$12.77

(71.18% upside)

Analyst Consensus: Strong Buy

Stock Forecasts